Literature DB >> 24773617

Usefulness of contrast-enhanced ultrasound with Sonazoid for evaluating liver abscess in comparison with conventional B-mode ultrasound.

Manabu Kishina1, Masahiko Koda, Shiho Tokunaga, Kennichi Miyoshi, Yuki Fujise, Jun Kato, Tomomitsu Matono, Takaaki Sugihara, Yoshikazu Murawaki.   

Abstract

AIM: The purpose of this study was to evaluate the usefulness of contrast-enhanced ultrasound (CEUS) with Sonazoid (perfluorobutane) in patients with liver abscess. Sonazoid is a contrast agent with a low mechanical index and is phagocytosed by Kupffer cells.
METHODS: Twenty-two patients with liver abscess were evaluated with conventional US, real-time CEUS with Sonazoid, and enhanced computed tomography (CT). After 0.5 mL of Sonazoid was administrated i.v., CEUS images in the vascular and post-vascular phases were observed.
RESULTS: Conventional US showed hypoechoic lesions in 13 (59.1%), isoechoic in four (18.2%), hyperechoic in two (9.1%), mixed echoic in two (9.1%) and undetected in one (4.8%) patient. CEUS showed perilesional enhancement in 19 (86.4%) lesions in the vascular phase and well-defined unenhanced areas in 22 (100%) lesions in the post-vascular phase. CEUS revealed that 18 abscesses were cystic type and three were honeycomb type. Twenty-one abscesses (95.5%) had clearer appearances on CEUS than on conventional US in regard to the extent of necrotic or liquefied lesions seen. We could confirm reduction of the lesions after therapy in 13 (92.9%) of 14 patients followed up by CEUS.
CONCLUSION: Most of the liver abscesses showed perilesional enhancement in the vascular phase and unenhanced areas in the post-vascular phase. The appearance of liver abscesses was clearer on CEUS than on conventional US. CEUS with Sonazoid can be a more effective diagnostic and therapeutic tool for liver abscess.
© 2014 The Japan Society of Hepatology.

Entities:  

Keywords:  contrast-enhanced ultrasound; conventional ultrasound; enhanced computed tomography; liver abscess; perfluorobutane

Year:  2014        PMID: 24773617     DOI: 10.1111/hepr.12347

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  7 in total

Review 1.  Modern role of clinical ultrasound in liver abscess and echinococcosis.

Authors:  Rita Barosa; João Pinto; Ana Caldeira; Eduardo Pereira
Journal:  J Med Ultrason (2001)       Date:  2016-12-08       Impact factor: 1.314

2.  Unenhanced areas revealed by contrast-enhanced abdominal ultrasonography with Sonazoid™ potentially correspond to colorectal cancer.

Authors:  Minoru Tomizawa; Mizuki Togashi; Fuminobu Shinozaki; Rumiko Hasegawa; Yoshinori Shirai; Midori Noritake; Yukie Matsuoka; Hiroaki Kainuma; Yasuji Iwasaki; Kazunori Fugo; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Takashi Kishimoto; Naoki Ishige
Journal:  Exp Ther Med       Date:  2016-11-03       Impact factor: 2.447

Review 3.  The Evolving Nature of Hepatic Abscess: A Review.

Authors:  Marianna G Mavilia; Marco Molina; George Y Wu
Journal:  J Clin Transl Hepatol       Date:  2016-06-15

4.  Characteristics of hepatic solitary necrotic nodules on contrast-enhanced ultrasonography.

Authors:  Chunyu Lu; Shaoshan Tang; Xiaoyue Zhang; Yang Wang; Kaiming Wang; Peng Shen
Journal:  BMC Gastroenterol       Date:  2021-01-25       Impact factor: 3.067

Review 5.  Contrast-enhanced ultrasound (CEUS) in abdominal intervention.

Authors:  Dean Y Huang; Gibran T Yusuf; Mohammad Daneshi; Raymond Ramnarine; Annamaria Deganello; Maria E Sellars; Paul S Sidhu
Journal:  Abdom Radiol (NY)       Date:  2018-04

6.  The Efficacy of Sonazoid-enhanced Ultrasonography in Decision-making for Liver Abscess Treatment.

Authors:  Masahiro Morita; Chikara Ogawa; Akina Omura; Teruyo Noda; Atsushi Kubo; Toshihiro Matsunaka; Hiroyuki Tamaki; Mitsushige Shibatoge; Hiroshi Seno; Yasunori Minami; Kazuomi Ueshima; Toshiharu Sakurai; Naoshi Nishida; Masatoshi Kudo
Journal:  Intern Med       Date:  2020-02-15       Impact factor: 1.271

7.  Prospective assessment of diagnostic efficacy and safety of SonazoidTM and SonoVue® ultrasound contrast agents in patients with focal liver lesions.

Authors:  Ke Lv; Hongyan Zhai; Yuxin Jiang; Ping Liang; Hui-Xiong Xu; Lianfang Du; Yi-Hong Chou; Xiaoyan Xie; YuKun Luo; Young Joon Lee; Jae Young Lee; Bing Hu; Baoming Luo; Yi Wang; Ying Luan; Christina Kalli; Kun Chen; Wenping Wang; Ja-Der Liang
Journal:  Abdom Radiol (NY)       Date:  2021-06-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.